ResearcherCurtin UniversityNo recent work listed
Aleksandra Adamska
Matched on ORCID iD 0000-0002-7152-4149; OpenAlex author ID A5070990412. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2017: 1 paper · 2018: 4 papers · 2019: 3 papers
Papers 8
- Pancreatic cancer tumorspheres are cancer stem-like cells with increased chemoresistance and reduced metabolic potential. Co-author DOI 10.1016/j.jbior.2019.02.001↗
- ABCC3 is a novel target for the treatment of pancreatic cancer. Co-author DOI 10.1016/j.jbior.2019.04.004↗
- Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer. Co-author DOI 10.1186/s13046-019-1308-7↗
- Molecular and cellular mechanisms of chemoresistance in pancreatic cancer. Co-author DOI 10.1016/j.jbior.2017.11.007↗
- GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine. First author DOI 10.1038/s41388-018-0390-1↗
- Epithelial plasticity is crucial for pancreatic cancer metastatic organotropism. Co-author DOI 10.21037/atm.2018.10.16↗
- ATP-binding cassette transporters in progression and clinical outcome of pancreatic cancer: What is the way forward? Co-author DOI 10.3748/wjg.v24.i29.3222↗
- Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies. Co-author DOI 10.3390/ijms18071338↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Marco Falasca · 8 shared papers, 2017–2019 · strength 0.90
- Paper Epithelial plasticity is crucial for pancreatic cancer metastatic organotropism. DOI 10.21037/atm.2018.10.16↗
- Paper ATP-binding cassette transporters in progression and clinical outcome of pancreatic cancer: What is the way forward? DOI 10.3748/wjg.v24.i29.3222↗
- Paper Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies. DOI 10.3390/ijms18071338↗
- Alice Domenichini · 4 shared papers, 2017–2019 · strength 0.40
- Paper Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies. DOI 10.3390/ijms18071338↗
- Paper Pancreatic cancer tumorspheres are cancer stem-like cells with increased chemoresistance and reduced metabolic potentia… DOI 10.1016/j.jbior.2019.02.001↗
- Paper ABCC3 is a novel target for the treatment of pancreatic cancer. DOI 10.1016/j.jbior.2019.04.004↗
- Vincenzo De Laurenzi · 3 shared papers, 2018–2019 · strength 0.23
- Paper ABCC3 is a novel target for the treatment of pancreatic cancer. DOI 10.1016/j.jbior.2019.04.004↗
- Paper Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer. DOI 10.1186/s13046-019-1308-7↗
- Paper GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increa… DOI 10.1038/s41388-018-0390-1↗
- Verena Damiani · 2 shared papers, 2019 · strength 0.17
- Riccardo Ferro · 2 shared papers, 2018–2019 · strength 0.15
- Silvano Paternoster · 1 shared paper, 2019 · strength 0.11
- Norbaini Binti Abdol Razak · 1 shared paper, 2018 · strength 0.09
- Aikaterini Emmanouilidi · 1 shared paper, 2018 · strength 0.09
- Omar Elaskalani · 1 shared paper, 2018 · strength 0.09
- Pat Metharom · 1 shared paper, 2018 · strength 0.09
- Yulia Y. Maxuitenko · 1 shared paper, 2019 · strength 0.08
- Adam B. Keeton · 1 shared paper, 2019 · strength 0.08
- Pierluigi Di Sebastiano · 1 shared paper, 2019 · strength 0.08
- Gary Anthony Piazza · 1 shared paper, 2019 · strength 0.08
- Charlotte E. Edling · 1 shared paper, 2018 · strength 0.07
- Owen James Sansom · 1 shared paper, 2018 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.